Literature DB >> 21212796

MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2.

N H Foley1, I Bray, K M Watters, S Das, K Bryan, T Bernas, J H M Prehn, R L Stallings.   

Abstract

MicroRNAs function as negative regulators of posttranscriptional gene expression, having major roles in cellular differentiation. Several neuroblastoma cell lines can be induced to undergo differentiation by all-trans-retinoic acid (ATRA) and are used for modeling signaling pathways involved in this process. To identify miRNAs contributing to differentiation, we profiled 364 loci following ATRA treatment of neuroblastoma cell lines and found miR-10a and miR-10b to be highly overexpressed in SK-N-BE, LAN5 and SHSY-5Y. Ectopic overexpression of these miRNAs led to a major reprogramming of the transcriptome and a differentiated phenotype that was similar to that induced by ATRA in each of these cell lines. One of the predicted downregulated miR-10a/b targets was nuclear receptor corepressor 2 (NCOR2), a corepressor of gene transcription, which is known to suppress neurite outgrowth. NCOR2 was experimentally validated as a direct target of miR-10a/b, and siRNA-mediated inhibition of this mRNA alone resulted in neural cell differentiation. Moreover, induction of differentiation could be blocked by ectopic upregulation of NCOR2 using an expression construct lacking the miR-10a/b 3' untranslated region target site. We conclude that miR-10a/b has major roles in the process of neural cell differentiation through direct targeting of NCOR2, which in turn induces a cascade of primary and secondary transcriptional alterations, including the downregulation of MYCN.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21212796      PMCID: PMC3114164          DOI: 10.1038/cdd.2010.172

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  36 in total

Review 1.  miR-10 in development and cancer.

Authors:  A H Lund
Journal:  Cell Death Differ       Date:  2009-05-22       Impact factor: 15.828

2.  MicroRNA-10b and breast cancer metastasis.

Authors:  Harriet E Gee; Carme Camps; Francesca M Buffa; Stefano Colella; Helen Sheldon; Jonathan M Gleadle; Jiannis Ragoussis; Adrian L Harris
Journal:  Nature       Date:  2008-10-23       Impact factor: 49.962

3.  Down-regulation of miR-17 family expression in response to retinoic acid induced neuronal differentiation.

Authors:  Natalie J Beveridge; Paul A Tooney; Adam P Carroll; Nham Tran; Murray J Cairns
Journal:  Cell Signal       Date:  2009-08-08       Impact factor: 4.315

4.  Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.

Authors:  Xabier Agirre; Antonio Jiménez-Velasco; Edurne San José-Enériz; Leire Garate; Eva Bandrés; Lucia Cordeu; Oscar Aparicio; Borja Saez; Germán Navarro; Amaia Vilas-Zornoza; Ignacio Pérez-Roger; Jesús García-Foncillas; Antonio Torres; Anabel Heiniger; María José Calasanz; Puri Fortes; José Román-Gómez; Felipe Prósper
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

5.  The impact of microRNAs on protein output.

Authors:  Daehyun Baek; Judit Villén; Chanseok Shin; Fernando D Camargo; Steven P Gygi; David P Bartel
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

6.  Integrated genomic profiling identifies two distinct molecular subtypes with divergent outcome in neuroblastoma with loss of chromosome 11q.

Authors:  M Fischer; T Bauer; A Oberthür; B Hero; J Theissen; M Ehrich; R Spitz; R Eils; F Westermann; B Brors; R König; F Berthold
Journal:  Oncogene       Date:  2009-11-09       Impact factor: 9.867

7.  MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma.

Authors:  Jakob Lovén; Nikolay Zinin; Therese Wahlström; Inga Müller; Petter Brodin; Erik Fredlund; Ulf Ribacke; Andor Pivarcsi; Sven Påhlman; Marie Henriksson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

8.  MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness.

Authors:  Cristina Evangelisti; Maria Carolina Florian; Isabella Massimi; Carlo Dominici; Giuseppe Giannini; Silvia Galardi; Maria Cristina Buè; Simone Massalini; Heather P McDowell; Elio Messi; Alberto Gulino; Maria Giulia Farace; Silvia Anna Ciafrè
Journal:  FASEB J       Date:  2009-08-27       Impact factor: 5.191

9.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.

Authors:  Li Ma; Julie Teruya-Feldstein; Robert A Weinberg
Journal:  Nature       Date:  2007-09-26       Impact factor: 49.962

10.  Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer.

Authors:  Frank Ulrich Weiss; Ines J Marques; Joost M Woltering; Danielle H Vlecken; Ali Aghdassi; Lars Ivo Partecke; Claus-Dieter Heidecke; Markus M Lerch; Christoph P Bagowski
Journal:  Gastroenterology       Date:  2009-09-10       Impact factor: 22.682

View more
  62 in total

Review 1.  MicroRNA, nutrition, and cancer prevention.

Authors:  Sharon A Ross; Cindy D Davis
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

2.  Retinoic acid and microRNA.

Authors:  Lijun Wang; Atharva Piyush Rohatgi; Yu-Jui Yvonne Wan
Journal:  Methods Enzymol       Date:  2020-03-28       Impact factor: 1.600

3.  Developmental exposure to valproic acid alters the expression of microRNAs involved in neurodevelopment in zebrafish.

Authors:  Neelakanteswar Aluru; Kristina L Deak; Matthew J Jenny; Mark E Hahn
Journal:  Neurotoxicol Teratol       Date:  2013-10-12       Impact factor: 3.763

Review 4.  The miR-10 microRNA precursor family.

Authors:  Disa Tehler; Nina Molin Høyland-Kroghsbo; Anders H Lund
Journal:  RNA Biol       Date:  2011-09-01       Impact factor: 4.652

Review 5.  The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis.

Authors:  Raquel Domingo-Fernandez; Karen Watters; Olga Piskareva; Raymond L Stallings; Isabella Bray
Journal:  Pediatr Surg Int       Date:  2012-12-29       Impact factor: 1.827

6.  Fenretinide reduces angiogenesis by downregulating CDH5, FOXM1 and eNOS genes and suppressing microRNA-10b.

Authors:  Elif Isil Yücel; Mehmet Sahin
Journal:  Mol Biol Rep       Date:  2020-01-10       Impact factor: 2.316

7.  MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway.

Authors:  Jennifer Lynch; Joanna Fay; Maria Meehan; Kenneth Bryan; Karen M Watters; Derek M Murphy; Raymond L Stallings
Journal:  Carcinogenesis       Date:  2012-03-01       Impact factor: 4.944

8.  MicroRNA-10a controls airway smooth muscle cell proliferation via direct targeting of the PI3 kinase pathway.

Authors:  Ruoxi Hu; Wenchi Pan; Alexey V Fedulov; William Jester; Matthew R Jones; Scott T Weiss; Reynold A Panettieri; Kelan Tantisira; Quan Lu
Journal:  FASEB J       Date:  2014-02-12       Impact factor: 5.191

9.  microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest.

Authors:  Zhenze Zhao; Xiuye Ma; Derek Sung; Monica Li; Adam Kosti; Gregory Lin; Yidong Chen; Alexander Pertsemlidis; Tzu-Hung Hsiao; Liqin Du
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

Review 10.  The roles of microRNAs in neuroblastoma.

Authors:  Hong Mei; Zhen-Yu Lin; Qiang-Song Tong
Journal:  World J Pediatr       Date:  2014-01-25       Impact factor: 2.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.